8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jul 25, 2005)

Filed July 25, 2005For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on July 25, 2005, primarily to report its financial results for the second quarter and the first six months ended June 30, 2005. The filing itself incorporates by reference a press release issued on the same date, which contains the detailed financial and operational performance data for the period. Investors should refer to this press release (Exhibit 99.1) for specifics on revenue, earnings, and other key performance indicators. This report serves as a notification mechanism for investors regarding the company's performance. While the 8-K document itself is brief, the accompanying press release is the crucial document for understanding Quest Diagnostics' financial condition and operational results during the reporting period. Investors interested in the company's financial health and future prospects should consult the attached press release for a comprehensive overview.

Key Highlights

  • 1Quest Diagnostics Incorporated filed an 8-K report on July 25, 2005.
  • 2The report's primary purpose is to announce financial results for the quarter and six months ended June 30, 2005.
  • 3The detailed financial results are provided in an attached press release (Exhibit 99.1).
  • 4The press release is incorporated by reference into the 8-K filing.
  • 5The filing serves as official notification of the company's operational and financial condition update.
  • 6Robert A. Hagemann, Senior Vice President and Chief Financial Officer, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce Quest Diagnostics Incorporated's financial results for the second quarter and the first six months of 2005, ending on June 30, 2005. It also serves to provide details on the company's financial condition during that period.

The actual detailed financial results are not contained within the 8-K document itself. Instead, they are presented in a press release issued by Quest Diagnostics on July 25, 2005, which is attached as Exhibit 99.1 and incorporated by reference into the 8-K filing.

Investors should look for key financial metrics such as revenue, earnings per share (EPS), net income, operating expenses, and any commentary on the factors influencing these results provided in the press release.

Robert A. Hagemann is the Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated. His signature indicates that he, as a duly authorized officer, has verified the accuracy and completeness of the information presented in this 8-K report on behalf of the company.